Clinical Outcomes and Risk Stratification in Patients With Metastatic Hormone-Sensitive Prostate Cancer Treated With New-Generation Androgen Receptor Signaling Inhibitors
Article in Clinical Genitourinary Cancer (June 2024)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Real-world retrospective study of prostate-specific antigen and safety assessment with darolutamide plus androgen deprivation therapy for metastasis hormone-sensitive prostate cancer
Article in Translational Andrology and Urology (March 2024)
Contemporary Systemic Therapy Intensification for Prostate Cancer: A Review for General Practitioners in Oncology
Article in Current Oncology (February 2024)